{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T03:33:20Z","timestamp":1782790400528,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.11.027","type":"journal-article","created":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T16:26:50Z","timestamp":1574526410000},"page":"1114-1119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Strengthening national teams of experts to support HPV vaccine introduction in Eastern Mediterranean countries: Lessons learnt and recommendations from an international workshop"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8003-7959","authenticated-orcid":false,"given":"Carine","family":"Dochez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah","family":"Al Awaidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezzeddine","family":"Mohsni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Bouskraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.11.027_b0005","unstructured":"Bruni L, Albero G, Serrano B, Mena M, G\u00f3mez D, Mu\u00f1oz J, Bosch FX, de Sanjos\u00e9 S. ICO\/IARC. Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 22 January 2019. [Last accessed 15 February 2019]."},{"issue":"1","key":"10.1016\/j.vaccine.2019.11.027_b0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"issue":"19","key":"10.1016\/j.vaccine.2019.11.027_b0015","first-page":"241","article-title":"Human papillomavirus vaccines: WHO position paper, May 2017","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2019.11.027_b0020","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"De Martel","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2019.11.027_b0025","unstructured":"International Agency for Research on Cancer. Globocan 2018. https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/23-Cervix-uteri-fact-sheet.pdf [Last accessed 19 March 2019]."},{"key":"10.1016\/j.vaccine.2019.11.027_b0030","unstructured":"World Health Organization. Global Vaccine Action Plan. WHO 2013. http:\/\/www.who.int\/immunization\/global_vaccine_action_plan\/GVAP_doc_2011_2020\/en\/ [Last accessed 15 February 2019]."},{"key":"10.1016\/j.vaccine.2019.11.027_b0035","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2214-109X(16)30099-7","article-title":"Bosch FX, de Sanjos\u00e9 S and Castellsagu\u00e9. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis","volume":"4","author":"Bruni","year":"2016","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.vaccine.2019.11.027_b0040","unstructured":"World Health Organization. https:\/\/www.who.int\/immunization\/en\/ [Last accessed 22 February 2019]."},{"key":"10.1016\/j.vaccine.2019.11.027_b0045","unstructured":"HPV Information Center. https:\/\/www.hpvcentre.net\/datastatistics.php [Last accessed 19 March 2019]."},{"key":"10.1016\/j.vaccine.2019.11.027_b0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jadohealth.2013.02.022","article-title":"Effective health interventiona for adolescents that could be integrated with human papillomavirus vaccination programmes","volume":"53","author":"Broutet","year":"2013","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.vaccine.2019.11.027_b0055","doi-asserted-by":"crossref","first-page":"vii","DOI":"10.1016\/j.vaccine.2012.05.038","article-title":"Extended Middle East and North Africa: cervical cancer and human papillomavirus: can we make the case for prevention in the \u201crelatively\u201d low prevalence region?","volume":"31S","author":"Seoud","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.027_b0060","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1016\/j.vaccine.2010.02.025","article-title":"Informing decision makers: Experience and process of 15 National Immunization Technical Advisory Groups","volume":"28S","author":"Gessner","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.027_b0065","doi-asserted-by":"crossref","unstructured":"Adjagba A, MacDonald NE, Ortega-P\u00e9rez I, Duclos P, 2016 Global NITAG Network Meeting Participants. Strenghtening and sustainability of national immunization technical advisory groups (NITAGs) globally: Lessons and recommendations from the founding meeting of the global NITAG network. Vaccine 2017; 35: 3007\u20133011.","DOI":"10.1016\/j.vaccine.2017.04.039"},{"key":"10.1016\/j.vaccine.2019.11.027_b0070","unstructured":"NITAG Resource Center. http:\/\/www.nitag-resource.org\/ [Last accessed 19 March 2019]."},{"key":"10.1016\/j.vaccine.2019.11.027_b0075","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pvr.2017.08.003","article-title":"Improving skills and institutional capacity to strengthen adolescent immunisation programmes and health systmes in African countries through HPV vaccine introduction","volume":"4","author":"Dochez","year":"2017","journal-title":"Papillomavirus Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1931552X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1931552X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:38:26Z","timestamp":1759401506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1931552X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X1931552X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.027","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strengthening national teams of experts to support HPV vaccine introduction in Eastern Mediterranean countries: Lessons learnt and recommendations from an international workshop","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}